Lance Alstodt - Feb 18, 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: President, CEO, COB, Director, 10%+ Owner
Signature: /s/ Lance Alstodt
Stock symbol: BRTX
Transactions as of: Feb 18, 2023
Transactions value $: -$1,118
Form type: 4
Date filed: 2/27/2023, 04:17 PM
Previous filing: Feb 17, 2023
Next filing: Mar 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRTX	Common Stock	Tax liability	-$1.12K	-374	-0.2%	$2.99	187K	Feb 18, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BRTX	Stock Option						293K	Feb 18, 2023	Common Stock	293K	$5.08	Direct	F3
holding	BRTX	Stock Option						42.1K	Feb 18, 2023	Common Stock	42.1K	$5.08	Direct	F4
holding	BRTX	Stock Option						107K	Feb 18, 2023	Common Stock	107K	$2.91	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were withheld from vested stock grant to pay the associated withholding taxes.
F2	Includes 98,862 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
F3	The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
F4	The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.
F5	The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 with the remaining 53,381 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.